Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Expands By 2,081.6%
Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Expands By 2,081.6%
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 1,372,200 shares, an increase of 2,081.6% from the December 15th total of 62,900 shares. Based on an average daily volume of 347,700 shares, the short-interest ratio is currently 3.9 days.
美恩醫藥集團有限公司（OTCMKTS：MAYNF — 獲得評級）是 12 月份短期利益大幅增加的目標。截至十二月三十日，共有 1,372,200 股股份的短期權益，較十二月十五日共有 62,900 股股份增加 2,081.6%。根據每日平均成交量為 347,700 股，短息比率目前為 3.9 天。
Mayne Pharma Group Price Performance
梅恩製藥集團價格表現
MAYNF stock remained flat at $0.15 on Tuesday. 300 shares of the company traded hands, compared to its average volume of 2,325. Mayne Pharma Group has a fifty-two week low of $0.12 and a fifty-two week high of $0.29. The stock's fifty day moving average is $0.16 and its two-hundred day moving average is $0.19.
週二，MAYNF 股票維持在 0.15 美元的水平。該公司的 300 股交易手，相比其平均交易量為 2,325。梅恩製藥集團擁有五十二周低點 0.12 美元和五十二周高點 0.29 美元。股票的五十日移動平均線為 0.16 美元，其 200 日移動平均線為 0.19 美元。
Mayne Pharma Group shares are going to reverse split before the market opens on Wednesday, January 18th. The 1-20 reverse split was announced on Wednesday, January 18th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, January 18th.
梅恩製藥集團股票將在 1 月 18 日星期三市場開盤之前逆轉分裂。1-20 反向分裂於 1 月 18 日星期三宣布。股東擁有的股份數量將在 1 月 18 日（星期三）市場收盤後進行調整。
Mayne Pharma Group Company Profile
美恩製藥集團公司簡介
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
梅恩醫藥集團有限公司是一家專業製藥公司，在澳大利亞、紐西蘭、美國、加拿大、歐洲和亞洲生產和銷售品牌和仿製藥產品。該公司通過四個部分運營：指標合同服務，國際，品牌產品和投資組合產品。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- United Airlines Soars Ahead of Earnings...Time to Deplane?
- Is Dividend King PPG Industries A Buy Before Earnings?
- Shocking New Documentary Exposes The Two Men Destroying America
- 3 Dividend Stocks For Passive Income
- UnitedHealth Group Stock: Is This The Bottom?
- 免費獲取有關梅恩製藥集團（MAYNF）的研究報告
- 美國聯合航空公司在收入前飆升... 時間去飛機？
- 股息王 PPG 行業是否在盈利前買入？
- 令人震驚的新紀錄片暴露了兩個摧毀美國的人
- 3 股息股票被動收入
- 聯合健康集團股票：這是底部嗎？
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
接收梅恩製藥集團日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收梅恩製藥集團及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。